On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.
FDA issues proposed guidelines for developing drugs for Alzheimer’s disease
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
